GMO U.S. Value ETF (NYSEARCA:GMOV – Get Free Report) saw a significant decrease in short interest during the month of September. As of September 15th, there was short interest totaling 484 shares, a decrease of 86.6% from the August 31st total of 3,614 shares. Based on an average daily trading volume, of 28,429 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the shares of the stock are short sold.
Hedge Funds Weigh In On GMO U.S. Value ETF
A number of institutional investors and hedge funds have recently made changes to their positions in GMOV. HighTower Advisors LLC raised its position in shares of GMO U.S. Value ETF by 1.8% during the 4th quarter. HighTower Advisors LLC now owns 123,110 shares of the company’s stock valued at $3,384,000 after buying an additional 2,182 shares in the last quarter. Essential Partners LLC increased its stake in GMO U.S. Value ETF by 8.6% during the first quarter. Essential Partners LLC now owns 60,238 shares of the company’s stock worth $1,692,000 after acquiring an additional 4,774 shares during the last quarter. J.W. Cole Advisors Inc. increased its stake in GMO U.S. Value ETF by 128.7% during the fourth quarter. J.W. Cole Advisors Inc. now owns 28,510 shares of the company’s stock worth $784,000 after acquiring an additional 16,044 shares during the last quarter. Kestra Private Wealth Services LLC purchased a new stake in GMO U.S. Value ETF during the first quarter valued at approximately $333,000. Finally, Pathway Financial Advisors LLC purchased a new stake in GMO U.S. Value ETF during the second quarter valued at approximately $246,000.
GMO U.S. Value ETF Stock Up 0.5%
NYSEARCA GMOV traded up $0.15 during trading on Friday, hitting $32.30. 1,063 shares of the stock traded hands, compared to its average volume of 16,237. GMO U.S. Value ETF has a 12-month low of $25.66 and a 12-month high of $33.47. The firm has a 50-day simple moving average of $32.25 and a 200-day simple moving average of $30.43. The company has a market capitalization of $96.89 million, a P/E ratio of 12.08 and a beta of 0.63.
GMO U.S. Value ETF Cuts Dividend
About GMO U.S. Value ETF
The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.
Recommended Stories
- Five stocks we like better than GMO U.S. Value ETF
- Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
- Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
- Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
Receive News & Ratings for GMO U.S. Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
